Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MNKD $0.55 0.0700 +14.58%
CASC $5.50 0.5300 +10.66%
BLCM $18.72 1.7400 +10.25%
SYRS $15.47 1.3900 +9.87%
CTIC $0.49 0.0430 +9.73%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

TRIL $6.70 -0.5000 -6.94%
MRTX $5.05 -0.2000 -3.81%
BPMC $27.01 -0.9900 -3.54%
RXDX $5.95 -0.2000 -3.25%
LBIO $6.00 -0.2000 -3.23%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

AMA To Do ‘Whatever We Can’ To Help Carry Out Health Law

(Washington Post/Kaiser Health News) July 3, 2013 - The American Medical Association will do “whatever we can in our power” to help implement the 2010 health care law, the group’s president said Tuesday.
read article (free registration required) 

Key 'Obamacare' Provision Delayed Until 2015

(MSNBC/The Maddow Blog) July 3, 2013 - News from the Obama administration about the employer mandate in the Affordable Care Act caused quite a stir last night, but it's worth pausing to appreciate the extent of the impact.
read article 

Group Finds Carcinogen in Pepsi Products

(ABC News/Associated Press) July 3, 2013 - An environmental group said Wednesday that the caramel coloring used in Pepsi still contains a worrisome level of a carcinogen, even after the drink maker said it would change its formula.
read article 

Christie Receives Award From Hackensack University Medical Center

( Record) July 2, 2013 - Gov. Christie has created a statewide environment that enhances medical research, enables the poor to have cancer screenings and regulates insurance coverage for some cancer drugs, hospital executives from Hackensack University Medical Center said as they presented him with a leadership award Tuesday.
read article 

Dr. Gregory Foltz, Who Founded Brain-Cancer Clinic, Dies at 50

(Seattle Times) July 2, 2013 - Dr. Gregory Foltz, whose focus and dedication to finding a cure for brain cancer helped create an important Seattle research institution, has died. He was 50.
read article 

House Republicans Seek More Information from CMS on Exempting Part B Drugs from Sequestration

(ASCO in Action) July 2, 2013 - The House Republican Leadership of the Energy and Commerce Committee sent a letter to Marilyn Tavenner, Administrator for the Centers for Medicaid and Medicare Services.
read article 

Congress Considers Medicare Physician Payment Reforms; Legislation Expected by End of Year

(ASH) July 2, 2013 - Committees in both the House of Representatives and the Senate continue to work on legislation to reform physician payment in Medicare.
read article 

Shut Down of Cell Survival Process Found to Influence Fate of Lung Cancer Tumors

(Rutgers CINJ) July 1, 2013 - New research from Rutgers Cancer Institute of New Jersey, Princeton University and other collaborators suggests that inactivation of an essential gene responsible for the cell survival process known as autophagy can suppress the growth of non-small-cell lung cancer tumors and render them more benign.
read press release 

Biomarker Predicts Risk of Breast Cancer Recurrence After Tamoxifen Treatment

(NCI Cancer Center News) July 1, 2013 - A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment.
read article 

Treated for Cancer, Two Men Now Appear Free of HIV

(NBC News) July 3, 2013 - Two men who had grueling bone marrow treatments for cancer are enjoying a happy side effect: They appear free of the AIDS virus, researchers reported on Wednesday.
read article 

Roche Gets FDA Priority Review for Leukemia Drug Obinutuzumab

(Morningstar/Dow Jones Newswires) July 3, 2013 - Roche Holding AG said Wednesday the U.S. Food and Drug Administration has granted a priority review for its obinutuzumab drug in the treatment of chronic lymphocytic leukemia, one of the most common forms of blood cancer.
read article 

Pierce Brosnan’s Daughter Charlotte Dies From Ovarian Cancer

(ABC News) July 2, 2013 - Pierce Brosnan’s daughter Charlotte has died after a three-year battle with the same disease that also claimed her mother’s life more than 20 years ago.
read article 

Dialysis Stocks Hit by Proposed U.S. Reimbursement Cuts

(Reuters) July 2, 2013 - A proposal to slash reimbursements to kidney dialysis centers in the United States drove down shares of Fresenius Medical Care AG and Davita Healthcare Partners Inc, two of the world's leading providers of dialysis services.
read article 

Pfizer’s Eliquis Stops Blood Clots as Well as Standard

(Bloomberg) July 1, 2013 - Eliquis, the blood thinner sold by Pfizer Inc. and Bristol-Myers Squibb Co., was as good as the current standard of care in preventing blood clots and with fewer bleeding complications, according to a study.
read article 

How Biotechs Got Hot

(Wall Street Journal) July 1, 2013 - Biotechnology companies are enjoying their best run with initial public offerings in a decade, amid an upswing in new drug approvals, strong performance by some already public biotech firms and legal changes.
read article (paid subscription required) 

International Conference to Take a Fresh Look at a Cancer-Causing Protein

(University of New Mexico Cancer Center) July 1, 2013 - MYB Conference to foster new research efforts to study protein mutation that causes cancer.
read press release 

Cancer Discovery Scores High in New Journal Rankings Report

(AACR) June 26, 2013 - Cancer Discovery, a journal of the American Association for Cancer Research (AACR), ranked ninth of 196 oncology-focused, peer-reviewed journals in terms of impact factor, according to the latest Journal Citation Report from Thomson-Reuters, the industry standard for journal impact measurement.
read press release 

GE Healthcare Research Determines Bad Habits Add $33.9 Billion to Annual Global Cost of Cancer

(Daily Finance) July 2, 2013 - GE Healthcare today released secondary research findings indicating that bad habits and lifestyle choices are contributing approximately $33.9 billion annually to the costs related to cancer.
read article 

New Clinical Practice Guidelines Address Diagnosis, Staging of Esophageal Cancer

(STS) July 1, 2013 - The Society of Thoracic Surgeons (STS) has released a set of clinical practice guidelines to address current and changing factors that affect the diagnosis and treatment of localized esophageal cancer.
read press release 

ARIAD Announces Marketing Authorization for Iclusig® (ponatinib) in the European Union

(TheStreet) July 2, 2013 - ARIAD Pharmaceuticals, Inc. today announced that the European Commission (EC) has granted a marketing authorization for Iclusig® (ponatinib) as an orphan medicinal product for two indications:
read article 

Roche Buys U.S. Blood-Testing Firm for Initial $220 Million

(Reuters) July 2, 2013 - Swiss drugmaker Roche Holding AG is buying Constitution Medical Investors (CMI), the U.S. developer of a testing system for blood diseases like anemia and leukemia, for an upfront $220 million, plus further contingent payments.
read article 

How Onyx Transformed Itself Into a Target

(Wall Street Journal) July 1, 2013 - Onyx Pharmaceuticals has developed itself from a struggling biotech company to a $10 billion acquisition target in just a few years.
read article (paid subscription required) 

Onyx Investors Shouldn't Count on Bayer Buying

(Wall Street Journal) July 1, 2013 - In biotech, deal valuations have a habit of defying gravity.
read article (paid subscription required) 

VentiRx Pharmaceuticals Initiates the ACTIVE8 Phase 2 Clinical Trial Evaluating VTX-2337 in Combination with Cetuximab and Chemotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

(Sacramento Bee) July 2, 2013 - VentiRx Pharmaceuticals, Inc. announced today the initiation of the ACTIVE8 clinical trial, a randomized, placebo-controlled, Phase 2 trial evaluating VTX-2337 in combination with a standard of care regimen, cetuximab, platinum and 5 Fluorouracil (5-FU), in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
read article 

Array BioPharma Initiates MEK162 Phase 3 MILO Study Triggering Milestone Payment

(MarketWatch July 2, 2013 - Array BioPharma Inc. announced today that a $5 million milestone was achieved after the start of Array's Phase 3 clinical trial in patients with low-grade serous ovarian cancer (LGSOC).
read article